Entera Bio Ltd. (ENTX) stock
ENTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.00−0.02 (-0.66%)
Close on Nov 17, 2026Market cap $519.43MP/E –Yield –
Entera Bio price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Entera Bio's price to book ratio was 21.8× on Nov 11, 2026, against 7.1× a year earlier. Over the last 5 years it ranged from 1.3× to 21.8×, with a median of 4.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 21.8× | +16.0 |
| 2025 | Dec 31, 2025 | 5.8× | −6.2 |
| 2024 | Dec 31, 2024 | 12.0× | +9.2 |
| 2023 | Dec 29, 2023 | 2.8× | +1.3 |
| 2022 | Dec 30, 2022 | 1.5× | −1.6 |
| 2021 | Dec 31, 2021 | 3.0× | +0.8 |
| 2020 | Jul 31, 2020 | 2.2× | – |
See a number that looks wrong?